Intas Pharmaceuticals Limited (manufacturing medicinal product, primary and secondary packaging, batch quality control)/Mitham Labs Ltd. (quality control)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in the event of disease recurrence or progression.
Dosage form: capsules, hard
Active substance Dosage temozolomide 20 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Dosage form: capsules, hard
Active substance Dosage temozolomide 100 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in the event of disease recurrence or progression.
Dosage form: capsules, hard
Active substance Dosage temozolomide 140 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Dosage form: capsules, hard
Active substance Dosage temozolomide 180 mg ATC: L01AX03
-
The drug is used for the treatment of adults with newly diagnosed glioblastoma multiforme (in combination with radiotherapy, and subsequently as monotherapy), as well as for children from 3 years of age and adults with malignant glioma (glioblastoma multiforme or anaplastic astrocytoma) in cases of disease recurrence or progression.
Dosage form: capsules, hard
Active substance Dosage temozolomide 250 mg ATC: L01AX03